wire
« BACK
Health - Innovation - 06.07.2022
Health - 06.07.2022
Health - Pharmacology - 05.07.2022
Health - Campus - 30.06.2022
Life Sciences - Health - 30.06.2022
Health - 30.06.2022
Health - Social Sciences - 29.06.2022
Health - 29.06.2022
Physics - Health - 28.06.2022 
Speech-friendly face mask could end frustration of muffled chat
A new face mask designed by Manchester researchers is promising to end the stress and anxiety talkers and listeners experience when they cover up. Designed by a team at The Universities of Manchester and Salford , and the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) , the revolutionary design will protect wearers from viruses such as COVID-19.
Health - Innovation - 28.06.2022
Health - Pharmacology - 27.06.2022 
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
Social Sciences - Health - 27.06.2022 
Trial of new treatment to prevent prisoner suicide launches
A new talking therapy for men in prison who struggle with suicidal thoughts and feelings is being launched in the UK. The team of clinicians, academics, researchers, service users and carers will study the effects of Cognitive Behavioural Suicide Prevention therapy within prisons. Suicide is the leading cause of preventable death in prisons in England and Wales with 86 prisoner deaths and 52,000 episodes of self-injury in 2021 alone, leaving prisoners five times more likely to take their own lives than the general population.
Health - Event - 27.06.2022
Health - Economics / Business - 27.06.2022
Pharmacology - Health - 24.06.2022
Health - Career - 24.06.2022
Health - Pharmacology - 22.06.2022 
COPD patients respond equally well to COVID-19 vaccine
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.
Health - 22.06.2022
Health - 22.06.2022
Health - 22.06.2022
Health - Pharmacology - 17.06.2022
Health - Social Sciences - 16.06.2022
Health - Pharmacology - 16.06.2022
Health - 16.06.2022 
Researchers receive £12m from Cancer Grand Challenges
Seven scientists at UCL will take on some of the toughest obstacles in cancer, after being selected to play leading roles in the latest global Cancer Grand Challenges.
Health - Pharmacology - 16.06.2022
Pharmacology - Health - 15.06.2022 
UK researchers pioneer new virtual treatment for PTSD
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).
Health - Life Sciences - 15.06.2022
Computer Science - Health - 14.06.2022 
Students develop software to revolutionise computer use for millions
Ground-breaking software that allows users to control their PC through their webcam using face and body movements has been developed by a team of UCL Computer Science students in collaboration with Intel, Microsoft, IBM, Google and the NHS.
Event - Health - 10.06.2022
Health - 09.06.2022
Health - Pedagogy - 08.06.2022
Health - 07.06.2022
Pharmacology - Health - 06.06.2022
Health - Life Sciences - 03.06.2022 
App detecting jaundice in babies a success in first major clinical trial
A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study co-authored by researchers at UCL (University College London) and the University of Ghana. The app, called neoSCB, was developed by clinicians and engineers at UCL and was used to screen for jaundice in over 300 newborn babies in Ghana, following an initial pilot study on 37 newborns at University College London Hospital (UCLH) in 2020.
Health - Campus - 01.06.2022
Health - Life Sciences - 31.05.2022 
Museum of Natural History to showcase Science Together community-researcher collaborations
Explore Science Together event at the Oxford University Museum of Natural History on Tuesday 7 June.
Health - Life Sciences - 27.05.2022
Life Sciences - Health - 27.05.2022
Health - Social Sciences - 27.05.2022 
Growing social and economic inequalities across north-west England are directly impacting health
A new report led by Professor Sir Michael Marmot (UCL Institute of Health Equity) exposes the growing social and economic inequalities in parts of north-west England and the impact it is having on people's health.
Health - Environment - 27.05.2022 
Opinion: AI could help us spot viruses like monkeypox before they cross over
Writing in The Conversation, Professor Patty Kostkova (UCL Institute for Risk & Disaster Reduction) and her colleagues describe how artificial Intelligence can be harnessed to better understand the interconnectedness of nature in order to protect it and us from future diseases.
Chemistry - Health - 26.05.2022 
Scientists win seven Royal Society of Chemistry Prizes
Five individuals and two teams from the University of Oxford have received prestigious prizes from the Royal Society of Chemistry today.
Pharmacology - Health - 26.05.2022
Innovation - Health - 26.05.2022 
Revolutionary ’EarSwitch’ project to be scaled up with new funding
New funding from NIHR will help to progress -EarSwitch the device that uses a hidden ear muscle to allow people with neurological conditions to communicate.
Health - Life Sciences - 25.05.2022 
Opinion: Catatonia - the person’s body may be frozen, but their minds are not
Writing in The Conversation, Dr Jonathan Rogers (UCL Psychiatry) describes new research explores what some people experiencing catatonia feel and think that overwhelms them to the point of being unable to move.
Health - 25.05.2022
Pharmacology - Health - 25.05.2022 
University spinout in major partnership to commercialize treatment for invasive aspergillosis
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.
Health - Life Sciences - 25.05.2022 
At-home blood test for juvenile-onset Huntington’s disease to be trialled
A blood test could screen children for juvenile-onset Huntington's disease, reports a new UCL-led study, ahead of a larger trial of an at-home finger prick test for the condition.
Social Sciences - Health - 25.05.2022
Health - Life Sciences - 24.05.2022 
Reducing TV viewing to less than one hour a day could help prevent more than one in ten cases of coronary heart disease
Watching too much TV is associated with increased risk of coronary heart disease regardless of an individual's genetic makeup, say a team of scientists at the University of Cambridge and the University of Hong Kong.
Health
Results 1 - 50 of 10238.
Dr Alex Casson selected for Academy of Medical Sciences’ FLIER cohort 3
Dr Alex Casson , Reader (Associate Professor) in the Department of Electrical and Electronic Engineering , has been chosen to join the third round of the Academy of Medical Sciences' highly competitive FLIER programme.
Dr Alex Casson , Reader (Associate Professor) in the Department of Electrical and Electronic Engineering , has been chosen to join the third round of the Academy of Medical Sciences' highly competitive FLIER programme.
Pandemic Sciences Institute formally launched in Oxford
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.
UK organisations release annual statistics for use of animals in research
The ten organisations in Great Britain that carry out the highest number of animal procedures - those used in medical, veterinary and scientific research - have today released their annual statistics.
The ten organisations in Great Britain that carry out the highest number of animal procedures - those used in medical, veterinary and scientific research - have today released their annual statistics.
Music in Mind Remote study
The NIHR School for Social Care Research (SSCR) has awarded researchers at The University of Manchester, Manchester Camerata , and the Greater Manchester Mental Health NHS Foundation Trust an 18-mont
The NIHR School for Social Care Research (SSCR) has awarded researchers at The University of Manchester, Manchester Camerata , and the Greater Manchester Mental Health NHS Foundation Trust an 18-mont
A new face mask designed by Manchester researchers is promising to end the stress and anxiety talkers and listeners experience when they cover up. Designed by a team at The Universities of Manchester and Salford , and the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) , the revolutionary design will protect wearers from viruses such as COVID-19.
’Hologram patients’ developed to help train doctors and nurses
A new partnership involving Cambridge University Hospitals (CUH) and the University's Faculty of Education, brings medical training using -mixed reality- technology one step closer.
A new partnership involving Cambridge University Hospitals (CUH) and the University's Faculty of Education, brings medical training using -mixed reality- technology one step closer.
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
A new talking therapy for men in prison who struggle with suicidal thoughts and feelings is being launched in the UK. The team of clinicians, academics, researchers, service users and carers will study the effects of Cognitive Behavioural Suicide Prevention therapy within prisons. Suicide is the leading cause of preventable death in prisons in England and Wales with 86 prisoner deaths and 52,000 episodes of self-injury in 2021 alone, leaving prisoners five times more likely to take their own lives than the general population.
Which patients with advanced prostate cancer will benefit from chemotherapy
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.
Heart surgery delays will cost lives, warns research
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .
New system that defines Huntington’s Disease will ’revolutionise’ drug trials
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.
Seven scientists at UCL will take on some of the toughest obstacles in cancer, after being selected to play leading roles in the latest global Cancer Grand Challenges.
Researchers in Glasgow to receive £1.9m to tackle late stage cancer syndrome
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).
Ground-breaking software that allows users to control their PC through their webcam using face and body movements has been developed by a team of UCL Computer Science students in collaboration with Intel, Microsoft, IBM, Google and the NHS.
Scottish primary school children help co-create new virus app
A new app, designed to help children understand more about respiratory viruses, has been co-created by staff from the University of Glasgow, The Glasgow School of Art and local primary school pupils in Glasgow.
A new app, designed to help children understand more about respiratory viruses, has been co-created by staff from the University of Glasgow, The Glasgow School of Art and local primary school pupils in Glasgow.
Study identifies best treatment for rare childhood cancer
High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.
High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.
A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study co-authored by researchers at UCL (University College London) and the University of Ghana. The app, called neoSCB, was developed by clinicians and engineers at UCL and was used to screen for jaundice in over 300 newborn babies in Ghana, following an initial pilot study on 37 newborns at University College London Hospital (UCLH) in 2020.
Explore Science Together event at the Oxford University Museum of Natural History on Tuesday 7 June.
Research project awarded £1m in funding to uncover new ’fingerprints’ of brain disease
Cardiff scientists have been awarded nearly £1m to investigate how the world's most powerful imaging technology can help to spot new signs of disease in the brain.
Cardiff scientists have been awarded nearly £1m to investigate how the world's most powerful imaging technology can help to spot new signs of disease in the brain.
A new report led by Professor Sir Michael Marmot (UCL Institute of Health Equity) exposes the growing social and economic inequalities in parts of north-west England and the impact it is having on people's health.
Writing in The Conversation, Professor Patty Kostkova (UCL Institute for Risk & Disaster Reduction) and her colleagues describe how artificial Intelligence can be harnessed to better understand the interconnectedness of nature in order to protect it and us from future diseases.
Five individuals and two teams from the University of Oxford have received prestigious prizes from the Royal Society of Chemistry today.
New funding from NIHR will help to progress -EarSwitch the device that uses a hidden ear muscle to allow people with neurological conditions to communicate.
Writing in The Conversation, Dr Jonathan Rogers (UCL Psychiatry) describes new research explores what some people experiencing catatonia feel and think that overwhelms them to the point of being unable to move.
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.
A blood test could screen children for juvenile-onset Huntington's disease, reports a new UCL-led study, ahead of a larger trial of an at-home finger prick test for the condition.
Watching too much TV is associated with increased risk of coronary heart disease regardless of an individual's genetic makeup, say a team of scientists at the University of Cambridge and the University of Hong Kong.
